Enochian Biosciences, Inc. (ENOB): Price and Financial Metrics

Enochian Biosciences, Inc. (ENOB): $0.70

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add ENOB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#311 of 385

in industry

ENOB Price/Volume Stats

Current price $0.70 52-week high $2.99
Prev. close $0.70 52-week low $0.39
Day low $0.70 Volume 88,300
Day high $0.75 Avg. volume 137,347
50-day MA $0.64 Dividend yield N/A
200-day MA $1.13 Market Cap 40.80M

ENOB Stock Price Chart Interactive Chart >


Enochian Biosciences, Inc. (ENOB) Company Bio


Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, focuses on development of human therapeutics for infectious diseases and cancers. The company's lead candidate include ENOB-HV-01 for autologous HIV curative treatment. Its pipeline development products consist of ENOB-HV-11, a preventive HIV vaccine; and ENOB-HV-12, a therapeutic HIV vaccine. The company's pipeline development products also include ENOB-HB-01, a coopting Hepatitis B polymerase; ENOB-DC-01, an off-the-shelf DC vaccine pulsed with MCV lysate; ENOB-DC-11 innovative DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intratumoral injection. The company has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Center, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. Enochian Biosciences, Inc. is headquartered in Los Angeles, California.


ENOB Latest News Stream


Event/Time News Detail
Loading, please wait...

ENOB Latest Social Stream


Loading social stream, please wait...

View Full ENOB Social Stream

ENOB Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -93.51%
5-year -88.07%
YTD N/A
2023 0.00%
2022 -85.87%
2021 147.12%
2020 -41.24%
2019 -28.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!